IE
Insider Edges

REGENERON PHARMACEUTICALS, INC. 13F portfolio summary

REGENERON PHARMACEUTICALS, INC. of REGENERON PHARMACEUTICALS, INC. has 1 current stock holdings with a reported portfolio value of $47.9M. The portfolio 1 year return is +130.52%. Top holdings include NTLA (100.00%).

Back to investors

REGENERON PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC.
Latest filing: 2026-03-31

REGENERON PHARMACEUTICALS, INC. runs REGENERON PHARMACEUTICALS, INC. and currently holds 1 stock positions, which is fewer than the average of 229 among the investors we track. The portfolio is valued at approximately $47.88M. Their top 5 holdings are various securities, which collectively represent 0.0% of the portfolio's total weight. REGENERON PHARMACEUTICALS, INC. ranks #73 out of 1000 investors tracked based on their composite Alpha Score. Over the past year, REGENERON PHARMACEUTICALS, INC.'s portfolio at REGENERON PHARMACEUTICALS, INC. has delivered returns of +130.52%. Their 3-year annualized return is +159.92%. Looking at the 5-year horizon, REGENERON PHARMACEUTICALS, INC. has achieved +159.92% annualized returns at REGENERON PHARMACEUTICALS, INC..

Sign in to enable email alerts for this investor.
Top 5 Holdings
No holdings data available
Portfolio Returns
1 Year
+130.52%
#36/1000
3 Year
+159.92%
#91/1000
5 Year
+159.92%
#89/1000

Portfolio Value

$47.88M

Alpha Score

142.2

#73 of 1000

Holdings

1

Showper page

0 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change